• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. VERSAPOINT ELECTRODE UNKNOWN PRODUCT; HYSTEROSCOPE (AND ACCESSORIES)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. VERSAPOINT ELECTRODE UNKNOWN PRODUCT; HYSTEROSCOPE (AND ACCESSORIES) Back to Search Results
Catalog Number VERSAUNK
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pain (1994); Uterine Perforation (2121); No Code Available (3191)
Event Type  Injury  
Manufacturer Narrative
(b)(4).This report is related to a journal article; therefore, no product will be returned for analysis and the batch history records cannot be reviewed as the lot number has not been provided.The single complaint was reported with multiple events.There are no additional details regarding the additional events.Attempts are being made to obtain the additional information.To date no response has been provided.If further details are received at the later date a supplemental medwatch will be sent.Were the cases discussed in this article previously reported to ethicon? if yes, please provide a complaint reference number.Does the surgeon believe that ethicon product (versapoint) involved caused and/or contributed to the post-operative complications described in the article? does the surgeon believe there was any deficiency with the ethicon product (versapoint) involved? patient demographics.Citation: journal of minimally invasive gynecology (2018) 00, 1-8; doi: https://doi.Org/10.1016/j.Jmig.2018.12.002.
 
Event Description
Title: effectiveness of hysteroscopic techniques for endometrial polyp removal: the italian multicenter trial.The aim of this prospective study was to compare the effectiveness and safety of different techniques of hysteroscopic polypectomy.Between january and december 2016, 1519 patients underwent hysteroscopic single/ multiple polypectomy, but 1404 (mean age 52.37 ± 12.65 years; mean bmi 24.97 ± 4.6 kg/m^2) were included in the study.Hysteroscopic polypectomy was performed by using 1 of the following instruments: double-flow 12fr or 16fr lens-based rigid hysteroscopes with 5fr operative channels, 26fr to 27fr resectoscopes armed with either monopolar or bipolar loops (versapoint bipolar system, gynecare; ethicon), 16fr monopolar/bipolar resectoscope, fiber-based 3.5-mm hysteroscope (versascope, gynecare; ethicon, inc.) with 7fr operative channel, or 13fr hysteroscopic morcellation system.Cutting instruments included mechanical tools (sharp scissors, grasping forceps, morcellators), electric tools 5fr coaxial bipolar disposable electrodes (versapoint bipolar system, gynecare), reusable electrodes bipolar loops or miniloops, monopolar loops or miniloops, and polyfiber diode laser probes.Surgical complications included perforation (=?); vasovagal syndrome (n=?); severe pelvic pain -vas >6 (n=5); penetration (n=?).In conclusion, outpatient polypectomy was associated with a minimal but significantly higher risk of residual endometrial polyps (eps) in comparison with inpatient polypectomy.Conversely, inpatient polypectomy was associated with a considerably higher risk of uterine perforation and penetration in comparison with office hysteroscopy.Because of lower intraoperative risks and higher cost effectiveness, office hysteroscopy may be considered, whenever possible, as the gold standard technique for removing eps.
 
Manufacturer Narrative
Date sent to the fda: 01/09/2020.
 
Manufacturer Narrative
Date sent to the fda: 1/9/2020.Additional information was requested, and the following was obtained: were the cases discussed in this article previously reported to ethicon? the cases discussed in this article were not previously reported to ethicon.Does the surgeon believe there was any deficiency with the ethicon product (versapoint) involved? versapoint did not show any deficiency.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.Does the surgeon believe that specific ethicon product such as versapoint electrodes/loops involved caused and/or contributed to the post-operative complication described in the article?.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERSAPOINT ELECTRODE UNKNOWN PRODUCT
Type of Device
HYSTEROSCOPE (AND ACCESSORIES)
Manufacturer (Section D)
ETHICON INC.
p.o. box 151, route 22 west
somerville NJ 08876
MDR Report Key9241718
MDR Text Key167438888
Report Number2210968-2019-89065
Device Sequence Number1
Product Code HIH
Combination Product (y/n)N
PMA/PMN Number
K040302
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Type of Report Initial,Followup,Followup
Report Date 09/27/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/25/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberVERSAUNK
Was Device Available for Evaluation? No
Date Manufacturer Received12/13/2019
Patient Sequence Number1
Treatment
UNK_VERSAPOINT RESECTOSCOPE.
Patient Outcome(s) Required Intervention;
-
-